Oncological resection and perioperative outcomes of robotic, laparoscopic and open pancreatoduodenectomy for ampullary adenocarcinoma: a propensity score matched international multicenter cohort study

Bas A. Uijterwijk*, Alma Moekotte, Ugo Boggi, Michele Mazzola, Bas Groot Koerkamp, Raffaele Dalle Valle, Sharnice Koek, Louisa Bolm, Alessandro Mazzotta, Misha Luyer, Brian K.P. Goh, Miguel A. Suarez Muñoz, Bergthor Björnsson, Geert Kazemier, Benedetto Ielpo, Patrick Pessaux, Jorg Kleeff, Poya Ghorbani, Vasileios K. Mavroeidis, Giuseppe K. FusaiRoberto Salvia, Alessandro Zerbi, Keith J. Roberts, Adnan Alseidi, Bilal Al-Sarireh, Mario Serradilla-Martín, Miljana Vladimirov, Dimitris Korkolis, Zahir Soonawalla, Mario Gruppo, Stefan A.W. Bouwense, Charles M. Vollmer, Stephen W. Behrman, John D. Christein, Marc G. Besselink, Mohammed Abu Hilal*, Laurence Webber, Ulrich Wellner, Mark Ramaekers, Ernesto Sparrelid, Giuseppe Malleo, Alejandro Ramirez-Del Val, Francesco Lancelotti, Gennaro Nappo, James Halle-Smith, Tara S. Kent, Judith de Vos-Geelen, Anouk de Wilde, Daniël H. Lemmers, Ricky Bhogal, International Study Group on non-pancreatic periampullary Cancer (ISGACA)

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Ampullary adenocarcinoma (AAC) typically presents at an early stage due to biliary obstruction and therefore might be specifically suitable for minimally invasive pancreatoduodenectomy (MIPD). However, studies assessing MIPD specifically for AAC, including the robotic and laparoscopic approach, are limited. The aim of this study is to compare short- and long-term oncological resection and perioperative outcomes of robotic (RPD), laparoscopic (LPD) and open pancreatoduodenectomy (OPD) performed specifically for AAC. Methods: In this multicenter international cohort study, encompassing 35 centers from 11 countries, MIPD versus OPD and subgroup analyses of LPD versus RPD were undertaken. The primary outcomes regarded the oncological resection (R1 resection rate, lymph node yield) and 5-years overall survival. Secondary outcomes were perioperative outcomes (including intra-operative variables, surgical complications and hospital stay). Results: In total, patients with AAC who underwent OPD (1721) or MIPD (141) were included. After propensity-score matching, 134 patients per cohort were included. The MIPD group consisted of 53 RPDs and 71 LPDs (50 per group after PSM). There was no difference in overall survival between MIPD and OPD (61.6 % vs 56.2 %, P = 0.215). In the MIPD group, operative time was longer (439 vs 360 min, P < 0.001). Between RPD and LPD, overall survival was not significantly different (75.8 % vs 47.4 %, P = 0.098) and lymph node yield was higher in RPD (21 vs 18, P = 0.014). Conclusion: In conclusion, patients with AAC seem to have comparable oncological resection and perioperative outcomes from MIPD compared to the traditional OPD. Both RPD as LPD appear to be safe alternatives for patients with AAC, which warrants confirmation by future randomized studies.

Original languageEnglish
Pages (from-to)318-329
Number of pages12
JournalHPB
Volume27
Issue number3
Early online date1 Jan 2025
DOIs
Publication statusPublished - Mar 2025

Fingerprint

Dive into the research topics of 'Oncological resection and perioperative outcomes of robotic, laparoscopic and open pancreatoduodenectomy for ampullary adenocarcinoma: a propensity score matched international multicenter cohort study'. Together they form a unique fingerprint.

Cite this